Najoh Tita-Reid, associated with bluebird bio, Inc., completed a stock acquisition on November 6, 2024. The transaction involved a grant of 24,900 shares of common stock at no cost. Following the transaction, Tita-Reid's direct holdings in the company increased to a total of 48,160 shares. The grant is part of the company's compensation strategy and reflects confidence in the long-term value of bluebird bio.

Najoh Tita-Reid, associated with bluebird bio, Inc., completed a stock acquisition on November 6, 2024. The transaction involved a grant of 24,900 shares of common stock at no cost. Following the transaction, Tita-Reid's direct holdings in the company increased to a total of 48,160 shares. The grant is part of the company's compensation strategy and reflects confidence in the long-term value of bluebird bio.